仙腸関節炎治療の世界市場レポート2025年

仙腸関節炎治療の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.2％で23億3,000万米ドルに成長します。この成長は、革新的な治療法の研究開発への投資拡大、慢性疼痛管理における遠隔医療サービスの利用増加、自己免疫疾患の増加、特定の経路を標的とする生物学的製剤治療へのアクセス拡大、個別化治療の重視の高まりなどに支えられると予測されます。この期間に予想される顕著な動向には、標的ドラッグデリバリーの革新、オーダーメイド治療レジメンの出現、再生療法ソリューションの進歩、ロボット支援手術技術の改善、統合治療プロトコルの進化などがあります。

関節障害の増加は、仙腸関節炎治療市場の成長を促進すると予想されます。関節障害には、関節の痛み、炎症、こわばり、動きの制限を引き起こす状態が含まれ、多くの場合、加齢、けが、自己免疫疾患、感染症などの要因によるものです。人口の高齢化に伴い、関節の摩耗や損傷が自然に増加し、変形性関節症やその他の退行性関節疾患のような症状の有病率が高くなります。仙腸関節炎治療は、仙腸関節の炎症と疼痛を軽減することで、可動性と関節機能を向上させ、症状を緩和し、さらなる損傷を防ぐという、関節疾患の管理において重要な役割を果たしています。例えば、2024年6月、オーストラリア保健福祉研究所（Australian Institute of Health and Welfare）は、変形性関節症が2022年に推定210万人のオーストラリア人（8.3％）に影響を与え、そのうち女性の10％、男性の6.1％が罹患していると報告しました。このような関節疾患の罹患率の増加が、仙腸関節炎治療市場の拡大に寄与しています。

仙腸関節炎治療市場の企業は、革新的な治療法の導入を促進し、市場アクセスを確保し、競争力を強化するために、薬事承認を優先しています。薬事承認は、政府の保健機関による正式な認可を意味し、医療が一般に使用される上で安全かつ効果的であることを確認するものです。2023年12月、米国の医療機器メーカーであるSpinal Simplicity社は、Liberty-SI Lateral Implant SystemのFDA 510（k）認可を取得しました。このシステムは、仙腸関節破壊や退行性仙腸関節炎などの患者の仙腸関節固定用に設計された低侵襲装置です。腸骨からSI関節を横切って仙骨に1～2本のチタン製インプラントを挿入し、安定化と固定を行う側方アプローチを採用しています。これらのインプラントは、中央にネジが切られたボディに、展開可能なウィングとコンプレッションエレメントを備え、様々なサイズがあり、骨との一体化を高めるためにハイドロキシアパタイトでコーティングされています。このシステムは侵襲性が低く、麻酔時間を短縮し、患者の予後を改善する可能性があります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の仙腸関節炎治療：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の仙腸関節炎治療市場：成長率分析
• 世界の仙腸関節炎治療市場の実績：規模と成長, 2019-2024
• 世界の仙腸関節炎治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界の仙腸関節炎治療：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界の仙腸関節炎治療市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品
• 関節注射
• 関節融合術
• 高周波神経除去
• 電気刺激
• 世界の仙腸関節炎治療市場：診断別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 画像検査
• 身体検査
• 臨床検査
• その他の診断
• 世界の仙腸関節炎治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口
• 注射
• 外用
• 世界の仙腸関節炎治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• 外来手術センター
• 在宅ケア設定
• 世界の仙腸関節炎治療市場、医薬品、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• NSAID（非ステロイド性抗炎症薬）
• コルチコステロイド
• 疾患修飾抗リウマチ薬（DMARD）
• 生物学的製剤
• 鎮痛剤
• 世界の仙腸関節炎治療市場、関節注射、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• コルチコステロイド注射
• 多血小板血漿（PRP）注射
• ヒアルロン酸注射
• プロロセラピー
• 世界の仙腸関節炎治療市場、関節固定、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 最小侵襲SI関節固定術
• 開放性SI関節固定術
• ロボット支援融合技術
• 後方アプローチ固定
• 外側アプローチ固定術
• 世界の仙腸関節炎治療市場、高周波デナーベーション、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 従来の高周波アブレーション
• 冷却高周波アブレーション
• パルスラジオ波アブレーション
• 世界の仙腸関節炎治療市場、電気刺激、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 経皮的電気神経刺激（TENS）
• 脊髄刺激療法（SCS）
• 末梢神経刺激（PNS）

第7章 地域別・国別分析

• 世界の仙腸関節炎治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の仙腸関節炎治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 仙腸関節炎治療市場：競合情勢
• 仙腸関節炎治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Boehringer Ingelheim International GmbH
• Amgen Inc.
• Biogen Inc.
• Sandoz Group AG
• UCB S.A.
• Hikma Pharmaceuticals PLC
• Samsung Bioepis Co. Ltd.
• Lupin Limited
• Zydus Lifesciences Limited
• Celltrion Healthcare Co. Ltd.
• Torrent Pharmaceuticals Limited
• Globus Medical
• Fortis Healthcare
• Orthofix Medical Inc.
• Coherus BioSciences Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 仙腸関節炎治療市場2029：新たな機会を提供する国
• 仙腸関節炎治療市場2029：新たな機会を提供するセグメント
• 仙腸関節炎治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Sacroiliitis treatment refers to the healthcare interventions used to address inflammation in one or both of the sacroiliac joints, which connect the lower spine to the pelvis. This condition often leads to pain in the lower back, buttocks, or legs and is frequently linked to inflammatory disorders such as ankylosing spondylitis. The main objective of sacroiliitis treatment is to alleviate inflammation, reduce pain, and improve mobility.

Key treatment options for sacroiliitis include medications, joint injections, joint fusion surgery, radiofrequency denervation, and electrical stimulation. Medications primarily involve nonsteroidal anti-inflammatory drugs (NSAIDs) and analgesics that are effective in easing inflammation and pain in the sacroiliac region. Diagnosis involves various methods such as imaging tests, physical exams, and laboratory diagnostics. These treatments are delivered through oral, injectable, or topical routes and are utilized in diverse settings including hospitals, specialty clinics, ambulatory surgical centers, and home care facilities.

The sacroiliitis treatment market research report is one of a series of new reports from The Business Research Company that provides sacroiliitis treatment market statistics, including sacroiliitis treatment industry global market size, regional shares, competitors with a sacroiliitis treatment market share, detailed sacroiliitis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the sacroiliitis treatment industry. This sacroiliitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sacroiliitis treatment market size has grown strongly in recent years. It will grow from $1.64 billion in 2024 to $1.77 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. This growth during the historical period was fueled by the increasing prevalence of lower back pain, a growing emphasis on early diagnosis, a surge in pelvic injuries from sports, greater use of advanced imaging methods, and a heightened preference for minimally invasive treatment options.

The sacroiliitis treatment market size is expected to see strong growth in the next few years. It will grow to $2.33 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The projected growth will be supported by greater investment in R&D for innovative therapies, the rising use of telehealth services in managing chronic pain, increasing occurrences of autoimmune disorders, broader access to biologic therapies targeting specific pathways, and a growing emphasis on personalized medical treatments. Prominent trends anticipated in this period include innovations in targeted drug delivery, emergence of customized treatment regimens, progress in regenerative therapy solutions, improvements in robotic-assisted surgical techniques, and the evolution of integrated treatment protocols.

The rising number of joint disorders is expected to drive the growth of the sacroiliitis treatment market. Joint disorders, which include conditions causing pain, inflammation, stiffness, and limited movement in the joints, are often due to factors such as aging, injury, autoimmune diseases, or infections. As populations age, there is a natural increase in wear and tear on joints, leading to a greater prevalence of conditions like osteoarthritis and other degenerative joint diseases. Sacroiliitis treatment plays a crucial role in managing joint disorders by reducing inflammation and pain in the sacroiliac joints, thereby improving mobility and joint function, which helps alleviate symptoms and prevent further damage. For example, in June 2024, the Australian Institute of Health and Welfare reported that osteoarthritis affected an estimated 2.1 million Australians (8.3%) in 2022, including 10% of women and 6.1% of men. This growing incidence of joint disorders is contributing to the expansion of the sacroiliitis treatment market.

Companies in the sacroiliitis treatment market are prioritizing regulatory approvals to facilitate the introduction of innovative therapies, ensure market access, and reinforce their competitive positions. Regulatory approvals signify formal authorization by government health agencies, confirming that a medical treatment is safe and effective for public use. In December 2023, Spinal Simplicity, a US-based medical equipment manufacturer, received FDA 510(k) clearance for its Liberty-SI Lateral Implant System. This system is a minimally invasive device designed for sacroiliac joint fusion in patients with conditions such as sacroiliac disruptions and degenerative sacroiliitis. It employs a lateral approach by inserting one or two titanium implants through the ilium and across the SI joint into the sacrum, providing stabilization and fusion. These implants have a central threaded body with deployable wings and compressive elements, come in various sizes, and are coated with hydroxyapatite to enhance bone integration. The system is designed to be less invasive, potentially shortening anesthesia time and improving patient outcomes.

In November 2023, Nevro Corp., a US-based medical device company focused on pain management solutions, acquired Vyrsa Technologies for an undisclosed amount. This acquisition is intended to enhance Nevro's portfolio of minimally invasive treatments and accelerate the adoption and development of Vyrsa's advanced spinal technologies by leveraging Nevro's commercial infrastructure and clinical expertise. Vyrsa Technologies is a US-based medical device firm that provides a minimally invasive treatment option for sacroiliitis, specifically concentrating on sacroiliac joint fusion.

Major players in the sacroiliitis treatment market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Biogen Inc., Sandoz Group AG, UCB S.A., Hikma Pharmaceuticals PLC, Samsung Bioepis Co. Ltd., Lupin Limited, Zydus Lifesciences Limited, Celltrion Healthcare Co. Ltd., Torrent Pharmaceuticals Limited, Globus Medical, Fortis Healthcare, Orthofix Medical Inc., Coherus BioSciences Inc., and SI-BONE Inc.

North America was the largest region in the sacroiliitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sacroiliitis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sacroiliitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sacroiliitis treatment market includes revenues earned by entities by providing services, such as anti-inflammatory medications, pharmacological treatment, physical therapy, interventional pain management, surgical services, and chiropractic and osteopathic services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sacroiliitis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sacroiliitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sacroiliitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sacroiliitis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Medications; Joint Injections; Joint Fusion; Radiofrequency Denervation; Electrical Stimulation
• 2) By Diagnosis: Imaging Tests; Physical Examination; Laboratory Tests; Other Diagnosis
• 3) By Route Of Administration: Oral; Injectable; Topical
• 4) By End-User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Home Care Settings
• Subsegments:
• 1) By Medications: NSAIDs (Nonsteroidal Anti-Inflammatory Drugs); Corticosteroids; Disease-Modifying Antirheumatic Drugs (DMARDs); Biologic Agents; Analgesics
• 2) By Joint Injections: Corticosteroid Injections; Platelet-Rich Plasma (PRP) Injections; Hyaluronic Acid Injections; Prolotherapy
• 3) By Joint Fusion: Minimally Invasive SI Joint Fusion; Open SI Joint Fusion; Robotic-Assisted Fusion Techniques; Posterior Approach Fusion; Lateral Approach Fusion
• 4) By Radiofrequency Denervation: Conventional Radiofrequency Ablation; Cooled Radiofrequency Ablation; Pulsed Radiofrequency Ablation
• 5) By Electrical Stimulation: Transcutaneous Electrical Nerve Stimulation (TENS); Spinal Cord Stimulation (SCS); Peripheral Nerve Stimulation (PNS)
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Novartis AG; Eli Lilly and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sacroiliitis Treatment Market Characteristics

3. Sacroiliitis Treatment Market Trends And Strategies

4. Sacroiliitis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sacroiliitis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Sacroiliitis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Sacroiliitis Treatment Market Growth Rate Analysis
• 5.4. Global Sacroiliitis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Sacroiliitis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Sacroiliitis Treatment Total Addressable Market (TAM)

6. Sacroiliitis Treatment Market Segmentation

• 6.1. Global Sacroiliitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medications
• Joint Injections
• Joint Fusion
• Radiofrequency Denervation
• Electrical Stimulation
• 6.2. Global Sacroiliitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging Tests
• Physical Examination
• Laboratory Tests
• Other Diagnosis
• 6.3. Global Sacroiliitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Injectable
• Topical
• 6.4. Global Sacroiliitis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Home Care Settings
• 6.5. Global Sacroiliitis Treatment Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• NSAIDs (Nonsteroidal Anti-inflammatory Drugs)
• Corticosteroids
• Disease-Modifying Antirheumatic Drugs (DMARDs)
• Biologic Agents
• Analgesics
• 6.6. Global Sacroiliitis Treatment Market, Sub-Segmentation Of Joint Injections, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroid Injections
• Platelet-Rich Plasma (PRP) Injections
• Hyaluronic Acid Injections
• Prolotherapy
• 6.7. Global Sacroiliitis Treatment Market, Sub-Segmentation Of Joint Fusion, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Minimally Invasive SI Joint Fusion
• Open SI Joint Fusion
• Robotic-Assisted Fusion Techniques
• Posterior Approach Fusion
• Lateral Approach Fusion
• 6.8. Global Sacroiliitis Treatment Market, Sub-Segmentation Of Radiofrequency Denervation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Conventional Radiofrequency Ablation
• Cooled Radiofrequency Ablation
• Pulsed Radiofrequency Ablation
• 6.9. Global Sacroiliitis Treatment Market, Sub-Segmentation Of Electrical Stimulation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transcutaneous Electrical Nerve Stimulation (TENS)
• Spinal Cord Stimulation (SCS)
• Peripheral Nerve Stimulation (PNS)

7. Sacroiliitis Treatment Market Regional And Country Analysis

• 7.1. Global Sacroiliitis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Sacroiliitis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sacroiliitis Treatment Market

• 8.1. Asia-Pacific Sacroiliitis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Sacroiliitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Sacroiliitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Sacroiliitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sacroiliitis Treatment Market

• 9.1. China Sacroiliitis Treatment Market Overview
• 9.2. China Sacroiliitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Sacroiliitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Sacroiliitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sacroiliitis Treatment Market

• 10.1. India Sacroiliitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Sacroiliitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Sacroiliitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sacroiliitis Treatment Market

• 11.1. Japan Sacroiliitis Treatment Market Overview
• 11.2. Japan Sacroiliitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Sacroiliitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Sacroiliitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sacroiliitis Treatment Market

• 12.1. Australia Sacroiliitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Sacroiliitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Sacroiliitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sacroiliitis Treatment Market

• 13.1. Indonesia Sacroiliitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Sacroiliitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Sacroiliitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sacroiliitis Treatment Market

• 14.1. South Korea Sacroiliitis Treatment Market Overview
• 14.2. South Korea Sacroiliitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Sacroiliitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Sacroiliitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sacroiliitis Treatment Market

• 15.1. Western Europe Sacroiliitis Treatment Market Overview
• 15.2. Western Europe Sacroiliitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Sacroiliitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Sacroiliitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sacroiliitis Treatment Market

• 16.1. UK Sacroiliitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Sacroiliitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Sacroiliitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sacroiliitis Treatment Market

• 17.1. Germany Sacroiliitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Sacroiliitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Sacroiliitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sacroiliitis Treatment Market

• 18.1. France Sacroiliitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Sacroiliitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Sacroiliitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sacroiliitis Treatment Market

• 19.1. Italy Sacroiliitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Sacroiliitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Sacroiliitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sacroiliitis Treatment Market

• 20.1. Spain Sacroiliitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Sacroiliitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Sacroiliitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sacroiliitis Treatment Market

• 21.1. Eastern Europe Sacroiliitis Treatment Market Overview
• 21.2. Eastern Europe Sacroiliitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Sacroiliitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Sacroiliitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sacroiliitis Treatment Market

• 22.1. Russia Sacroiliitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Sacroiliitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Sacroiliitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sacroiliitis Treatment Market

• 23.1. North America Sacroiliitis Treatment Market Overview
• 23.2. North America Sacroiliitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Sacroiliitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Sacroiliitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sacroiliitis Treatment Market

• 24.1. USA Sacroiliitis Treatment Market Overview
• 24.2. USA Sacroiliitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Sacroiliitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Sacroiliitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sacroiliitis Treatment Market

• 25.1. Canada Sacroiliitis Treatment Market Overview
• 25.2. Canada Sacroiliitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Sacroiliitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Sacroiliitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sacroiliitis Treatment Market

• 26.1. South America Sacroiliitis Treatment Market Overview
• 26.2. South America Sacroiliitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Sacroiliitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Sacroiliitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sacroiliitis Treatment Market

• 27.1. Brazil Sacroiliitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Sacroiliitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Sacroiliitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sacroiliitis Treatment Market

• 28.1. Middle East Sacroiliitis Treatment Market Overview
• 28.2. Middle East Sacroiliitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Sacroiliitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Sacroiliitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sacroiliitis Treatment Market

• 29.1. Africa Sacroiliitis Treatment Market Overview
• 29.2. Africa Sacroiliitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Sacroiliitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Sacroiliitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sacroiliitis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Sacroiliitis Treatment Market Competitive Landscape
• 30.2. Sacroiliitis Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

31. Sacroiliitis Treatment Market Other Major And Innovative Companies

• 31.1. Boehringer Ingelheim International GmbH
• 31.2. Amgen Inc.
• 31.3. Biogen Inc.
• 31.4. Sandoz Group AG
• 31.5. UCB S.A.
• 31.6. Hikma Pharmaceuticals PLC
• 31.7. Samsung Bioepis Co. Ltd.
• 31.8. Lupin Limited
• 31.9. Zydus Lifesciences Limited
• 31.10. Celltrion Healthcare Co. Ltd.
• 31.11. Torrent Pharmaceuticals Limited
• 31.12. Globus Medical
• 31.13. Fortis Healthcare
• 31.14. Orthofix Medical Inc.
• 31.15. Coherus BioSciences Inc.

32. Global Sacroiliitis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sacroiliitis Treatment Market

34. Recent Developments In The Sacroiliitis Treatment Market

35. Sacroiliitis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Sacroiliitis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Sacroiliitis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Sacroiliitis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer